| P50 | author | Nesrine Mejri | Q96250289 |
| P2093 | author name string | H Boussen | |
| | N Daoud | |
| | S Labidi | |
| | H El Benna | |
| | M Dridi | |
| P2860 | cites work | Postoperative adjuvant chemotherapy in rectal cancer operated for cure | Q24201072 |
| | Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer | Q24202425 |
| | Follow-up of patients with curatively resected colorectal cancer: a practice guideline | Q24641986 |
| | A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer | Q26739607 |
| | Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database. | Q30315675 |
| | Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data | Q30884451 |
| | Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials | Q33397671 |
| | Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials | Q33432180 |
| | Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial | Q34607843 |
| | Recurrence and Five -Year Survival in Colorectal Cancer Patients After Surgery | Q36163287 |
| | Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis | Q38269844 |
| | Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project | Q39545521 |
| | Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study | Q41155680 |
| | DNA ploidy, tumour site, and prognosis in colorectal cancer. A flow cytometric study of paraffin-embedded tissue | Q41745079 |
| | Variations in Metastasis Site by Primary Location in Colon Cancer | Q48198221 |
| | Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. | Q53601981 |
| | Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients | Q58614888 |
| P433 | issue | 12 | |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 1524-1530 | |
| P577 | publication date | 2017-06-06 | |
| P1433 | published in | Clinical and Translational Oncology | Q15754324 |
| P1476 | title | Annual hazard rate of relapse of stage II and III colorectal cancer after primary therapy | |
| P478 | volume | 19 | |